Use of Pramlintide in Artificial Pancreas Systems May Improve T1D Glucose Control at Mealtimes Posted on December 31, 2012 by rlewinson
Dexcom G4 Platinum Continuous Glucose Monitor Approved by FDA Posted on December 31, 2012 by rlewinson
A Dual Hormone Artificial Pancreas System Successfully Tested in Two-Day Hospital-Based Studies Posted on December 31, 2012 by rlewinson
Modular Design Facilities Artificial Pancreas Software Development and Testing Posted on July 1, 2012 by JDRF
Clinical Study Suggests Low Glucose Suspend is Safe in Individuals with Hypoglycemia Unawareness Posted on April 1, 2012 by JDRF
APP Study Shows Significant Improvement in Continuous Glucose Monitor Accuracy with Multiple Redundant Sensors Posted on January 1, 2012 by JDRF
First U.S. Outpatient Artificial Pancreas Trial Receives FDA Approval Posted on January 1, 2012 by JDRF
FDA Issues Draft Guidance on Artificial Pancreas Device Systems for Investigational Device Exemption and Premarket Approval Applications Posted on October 1, 2011 by JDRF